Cambria Investment Management’s Pfizer PFE Stock Holding History

Cambria Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Buy	373,893 +6,465	+2%	+$172K	0.59%	18
2025 Q4	$9.15M	Sell	367,428 -30,319	-8%	-$765K	0.53%	37
2025 Q3	$10.1M	Buy	397,747 +30,156	+8%	+$744K	0.62%	40
2025 Q2	$8.91M	Sell	367,591 -55,014	-13%	-$1.28M	0.6%	68
2025 Q1	$10.7M	Buy	+422,605	New	+$11.1M	0.75%	52
2016 Q2	–	Sell	-48,308	Closed	-$1.36M	–	185
2016 Q1	$1.36M	Sell	48,308 -4,922	-9%	-$141K	0.63%	82
2015 Q4	$1.63M	Sell	53,230 -3,446	-6%	-$108K	0.65%	63
2015 Q3	$1.69M	Sell	56,676 -14,274	-20%	-$458K	0.65%	63
2015 Q2	$2.26M	Buy	70,950 +492	+0.7%	+$16K	0.69%	62
2015 Q1	$2.33K	Buy	70,458 +3,445	+5%	+$110K	0.26%	65
2014 Q4	$1.98M	Buy	+67,013	New	+$1.92M	0.71%	77

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cambria Investment Management's PFE Position: Q1 2026 in Review

Cambria Investment Management increased its Pfizer (PFE) stake by 1.8% in Q1 2026, buying an estimated $172K and bringing the position to 373,893 shares worth $10.5M. The position accounts for 0.59% of the portfolio, ranked #18.

Cambria Investment Management first reported a position in PFE in Q4 2014 and has held it in 11 quarters since. The position peaked at $10.7M in Q1 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Cambria Investment Management held 373,893 shares of Pfizer worth $10.5M as of Q1 2026.
Cambria Investment Management bought 6,465 Pfizer shares in Q1 2026, an estimated $172K.
Pfizer made up 0.59% of Cambria Investment Management's portfolio in Q1 2026, its #18 holding.
Cambria Investment Management first reported a position in Pfizer in Q4 2014 and has held it in 11 quarters since.
Cambria Investment Management's Pfizer position peaked at $10.7M in Q1 2025.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.